| Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272) |
|---|
| 07/05/2007 | WO2007074034A1 Workup in the preparation of high-purity triethylenediamine |
| 07/05/2007 | WO2007058392A9 Heterocyclic compound and medicinal application thereof |
| 07/05/2007 | WO2007056281A3 Multivalent indole compounds and use thereof as phospholipase-a2 inhibitors |
| 07/05/2007 | WO2007056184A3 Azaindole compounds and use thereof as phospholipase-a2 inhibitors |
| 07/05/2007 | WO2007038058A3 Amino-aza-adamantane derivatives and methods of use |
| 07/05/2007 | WO2007009101A3 Tetraazaporphyrin-based compounds and their uses |
| 07/05/2007 | WO2006057946A3 Tubulin binding anti cancer agents and prodrugs thereof |
| 07/05/2007 | WO2006055434A3 Macrocyclic tertiary amine beta-secretase inhibitors for the treatment of alzheimer's disease |
| 07/05/2007 | US20070155995 Two-phase method for the synthesis of selected pyrazolopyrimidines |
| 07/05/2007 | US20070155965 Substituted bicyclic imidazo-3-ylamine compounds |
| 07/05/2007 | US20070155963 intermediates for the synthesis of porphyrin rods useful in the production of molecular memory devices, light harvesting molecules, or in photodynamic therapy; 1,1-bis(5-thio-substituted-pyrrol-2-yl)ethane compounds as intermediates |
| 07/05/2007 | US20070155962 Process for preparing titanyl phthalocyanine |
| 07/05/2007 | US20070155961 Method for preparing phthalocyanines |
| 07/05/2007 | US20070155818 3-[5-ethoxy-1-(4-ethyl-benzenesulfonyl)-1H-indol-3-yl]-propionic acid for example; obesity, diabetes, syndrome X, breast or thyroid cancer, inflammatory skin disorders such as psoriasis, cardiovascular disorders, eating disorders such as bulimia; peroxisome proliferator-activated receptors (PPAR) agonist |
| 07/05/2007 | US20070155814 Immunomodulatory compositions |
| 07/05/2007 | US20070155795 Muscarinic agonists |
| 07/05/2007 | US20070155790 Meta-benzamidine derivatives as serine protease inhibitors |
| 07/05/2007 | US20070155761 Indol-3-yl-carbonyl-spiro-piperidine derivatives |
| 07/05/2007 | US20070155760 Adenosine A2a receptors antagonist; 9H-indeno[2,1-c]pyridine-4-carboxylic acid, 3-amino-1-furan-2-yl-9-oxo-, 2-dimethylamino-ethyl ester; neurodegenerative and movement disease, as Parkinson's; improves binding affinity of Dopamine D2 agonist to their receptors |
| 07/05/2007 | US20070155751 Imidazo(1,2-a)pyrazine compounds |
| 07/05/2007 | US20070155749 Derivatives of 1,4-diazabicyclo[3.2.1]octanecarboxamide, preparation method thereof and use of same in therapeutics |
| 07/05/2007 | US20070155738 Heterobicyclic metalloprotease inhibitors |
| 07/05/2007 | US20070155737 Heterobicyclic metalloprotease inhibitors |
| 07/05/2007 | US20070155731 Aminocyclopentyl pyridopyrazinone modulators of chemokine receptor activity |
| 07/05/2007 | US20070155730 Benzodiazepine And Benzopiperazine Analog Inhibitors Of Histone Deacetylase |
| 07/05/2007 | US20070155729 Therapeutic amine-arylsulfonamide conjugate compounds |
| 07/05/2007 | US20070155727 Amide inhibitors of leukotriene A4 hydrolase |
| 07/05/2007 | US20070155725 N-(1-Aza-bicyclo[2.2.2]oct-3-yl)-5-cyano-2-(3,5-dichloro-phenoxy)-benzenesulfonamide; asthma, allergic rhinitis or lung granuloma, HIV; CC type chemokine receptor antagonist |
| 07/05/2007 | US20070155722 Fused pyrazole derivatives as tgf-beta signal transduction inhibitors for the treatment of fibrosis and neoplasms |
| 07/05/2007 | US20070155713 Nitrogen-containing heterocyclic compounds and use thereof |
| 07/05/2007 | US20070155671 e.g. N-[2-chloro-4-[[[(3-hydroxyphenyl)methyl]amino]carbonyl]benzoyl]-3-(phenylmethyl)amino-L-alanine; intercellular adhesion molecules blocking agent; antiinflammatory; reperfusion injury following acute myocardial infarction |
| 07/05/2007 | US20070155670 Pyrrolidine Melanocortin-Specific Compounds |
| 07/05/2007 | US20070154948 Novel antibacterial agents |
| 07/05/2007 | US20070152189 Light-harvesting discotic liquid crystalline porphyrins and metal complexes |
| 07/05/2007 | US20070151600 As high-efficiency photovoltaic materials, organic semiconducting materials, and organic light emitting materials |
| 07/05/2007 | US20070151046 Neutral and cationic naphthalene and colorants for keratin fibers containing these compounds |
| 07/05/2007 | DE102005062990A1 Substituierte Thiazole und ihre Verwendung zur Herstellung von Arzneimitteln Substituted thiazoles and their use for the preparation of medicaments |
| 07/05/2007 | DE102005062987A1 Substituierte Propiolsäureamide und ihre Verwendung zur Herstellung von Arzneimitteln Substituted Propiolsäureamide and their use for the preparation of medicaments |
| 07/05/2007 | DE102005061997A1 New naphthalene compound useful, e.g. in semiconductors, preferably organic field effect transistor and photovoltaic units and as UV-absorber and optical brightener |
| 07/05/2007 | CA2634721A1 Triazolopyridazines as tyrosine kinase modulators |
| 07/05/2007 | CA2634630A1 Process for the preparation of porphyrin derivatives as antimicrobial agents by photodynamic therapy (pdt) |
| 07/05/2007 | CA2633992A1 Pyrimidine derivatives useful as inhibitors of pkc-theta |
| 07/05/2007 | CA2633962A1 Dimers and adducts of 6-[(substituted) phenyl] triazolopyrimidines useful as anticancer agents |
| 07/05/2007 | CA2631661A1 Nitroimidazole compounds |
| 07/04/2007 | EP1803723A1 (2,4,9-triaza-1(2,4)-pyrimidina-3(1,3)-benzenacyclononaphan-3^4-yl)-sulfoximide derivatives as selective inhibitors of the aurora kinase for the treatment of cancer |
| 07/04/2007 | EP1803720A1 Heterocyclindazole and -azaindazole compounds as 5-hydroxytryptamine-6 ligands |
| 07/04/2007 | EP1803710A1 Pyrimidine derivative condensed with non-aromatic ring |
| 07/04/2007 | EP1803709A1 Proton pump inhibitors |
| 07/04/2007 | EP1802637A1 Cgrp receptor antagonists |
| 07/04/2007 | EP1802628A1 Crystalline forms and process for preparing spiro-hydantoin compounds |
| 07/04/2007 | EP1802627A1 Pyrazolo (1,5-alpha) pyrimidinyl derivatives useful as corticotropin-releasing factor (crf) receptor antagonists |
| 07/04/2007 | EP1802626A1 Pyrrolotriazine compounds |
| 07/04/2007 | EP1802625A1 Disubstituted pyrazolobenzodiazepines useful as inhibitors for cdk2 and angiogesis, and for the treatment of breast, colon, lung and prostate cancer |
| 07/04/2007 | EP1802372A2 Cgrp receptor antagonists |
| 07/04/2007 | EP1644343B1 5-substituted quinazolinone derivatives |
| 07/04/2007 | EP1513843B1 Pyrazolopyrimidines and the use thereof for controlling harmful organisms |
| 07/04/2007 | EP1368579B1 Synthetic molecular spring device |
| 07/04/2007 | CN1993364A Hexahydro-pyrazino[1,2-a]pyrimidine-4,7-dione derivatives substituted with amino acids |
| 07/04/2007 | CN1993363A 1,3-disubstituted heteroaryl nmda/nr2b antagonists |
| 07/04/2007 | CN1993362A 稠合的杂环化合物 Fused heterocyclic compounds |
| 07/04/2007 | CN1993361A Pyrrolotriazine derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis |
| 07/04/2007 | CN1993360A Condensed pyridines as kinase inhibitors |
| 07/04/2007 | CN1993130A Processes and intermediates useful for preparing fused heterocyclic kinase inhibitors |
| 07/04/2007 | CN1990474A 11-beta-hydroxysteroid dehydrogenase 1 inhibitors useful for the treatment of diabetes, obesity and dyslipidemia |
| 07/04/2007 | CN1324092C Rylene dyes |
| 07/04/2007 | CN1324031C 2-substitution 6H-imidazol[1,2-b]-1,2,4-triazole-6-ketone possessing fungicidal property and preparation method |
| 07/04/2007 | CN1324030C Fungicidal triazolopyrimidines, methods for producing the same, use thereof for combating harmful fungi and agents containing said substances |
| 07/04/2007 | CN1324028C Variolin derivatives as anti-cancer agents |
| 07/04/2007 | CN1324012C TNF-alpha prodn. inhibitors |
| 07/03/2007 | US7238818 Heterocyclic metallocenes and polymerization catalysts |
| 07/03/2007 | US7238813 Antiproliferative agents; angiogenesis factor; wound healing agents; antiischemic agents; anticholesterol agents; antitumor, anticancer agents |
| 07/03/2007 | US7238812 2-(1-isopropoxycarbonyloxy-2-methylpropyl)-7,8-dimethoxy-4(5H),10 -dioxo-2H-1,2,3-triazolo(4,5-c)(1)benzazepine, for example; chemical intermediates, synthesis using relatively inexpensive reagents |
| 07/03/2007 | US7238811 Chemical compounds |
| 07/03/2007 | US7238808 Acetylenyl-pyrazolo-pyrimidine derivatives |
| 07/03/2007 | US7238802 Intermediates for synthesis of vinblastines, process for preparation of the intermediates and process for synthesis on vinblastines |
| 07/03/2007 | US7238801 For plasma display panel; near infrared radiation-shielding film possessing prominent ability to shield off near infrared radiation and ability to transmit visible radiation |
| 07/03/2007 | US7238721 Pyrazole compounds for treatment of neurodegenerative disorders |
| 07/03/2007 | US7238713 Muscarinic agonists |
| 07/03/2007 | US7238709 Respiratory system disorders; bronchitis; irritable bowel disorders; incontinence |
| 07/03/2007 | US7238704 For use as inhibitors of cellular mitosis and proliferation |
| 07/03/2007 | US7238703 Azabicyclic, azatricyclic and azaspirocyclic derivatives of aminocyclohexane NMDA, 5HT3, and neuronal nicotinic receptor antagonists |
| 07/03/2007 | US7238702 Dihydroquinazolinones as 5HT modulators |
| 07/03/2007 | US7238699 Imidazolyl derivatives as corticotropin releasing factor inhibitors |
| 07/03/2007 | US7238695 Imidazolyl derivatives |
| 07/03/2007 | US7238693 Gastrointestinal disorders; central nervous system disorders; cardiovascular disorders |
| 07/03/2007 | US7238692 Stent or a drug delivery or elution device with a disposed traiazine compound such as 6-(3-Chloro-4-methoxy-phenoxy)-N-cycloheptyl-N'-methyl-N'-(1-methyl-piperidin-4-yl)-[1,3,5]triazine-2,4-diamine for inhibiting smooth muscle proliferation; restenosis and atherosclerosis |
| 07/03/2007 | US7238691 Piperidine derivatives and their use as modulators of chemokine (especially CCR3) activity |
| 07/03/2007 | US7238690 Substituted heterocycle fused gamma-carbolines |
| 07/03/2007 | US7238688 For therapy of allergy, allergy-induced airway responses, congestion, hypotension, cardiovascular disease, hypotension, diseases of the GI tract, hyper and hypo motility and acidic secretion of the gastrointestinal tract, obesity, sleep |
| 07/03/2007 | US7238685 E.g., substituted 2,3,5,10b-tetraaza-benzo[e]azulen-6-yl)-acetic acids, 2,3,4,5-tetrahydro-1H-benzo[e][1,4]diazepin-5-yl)-(4,6-dimethoxy-pyrimidin-2-yloxy)-acetic acids and 2,3,4,5-tetrahydro-benzo[e][1,4]diazepin-1-ylmethyl}-benzoates; treating vasoconstriction, proliferation and inflammation |
| 07/03/2007 | US7238683 (Cycloalkyleneiminocarbonyl)-indanyl- or -tetrahydronaphthyl- methylamines, e.g., {(1S)-1-[(1S)-5-(4-Fluorophenyl)-2,3-dihydro-1H-inden-1-yl]-2-[(3S)-3-fluoropyrrolidin-1-yl]-2-oxoethyl}amine hydrochloride; particularly for treating type 2 diabetes |
| 07/03/2007 | CA2260774C Substituted triazolo-pyridazine derivatives as ligands for gaba receptors |
| 07/03/2007 | CA2188306C Process for the diastereoselective synthesis of nucleoside analogues |
| 06/28/2007 | WO2007072651A1 Cellulose ester film for optical use, and polarizing plate and liquid crystal display using such cellulose ester film for optical use |
| 06/28/2007 | WO2007072158A2 Pyrimidine derivatives for the treatment of abnormal cell growth |
| 06/28/2007 | WO2007071965A2 Antibacterial pyrrolopyridines, pyrrolopyrimidines, and pyrroloazepines |
| 06/28/2007 | WO2007071738A1 Condensed heterocyclic compounds useful as dpp-iv inhibitors |
| 06/28/2007 | WO2007071434A1 Antiviral 2-carboxy-thiophene compounds |
| 06/28/2007 | WO2007071393A2 Sulphonamidoaniline derivatives being janus kinases inhibitors |
| 06/28/2007 | WO2007071379A1 PYRROLO [l,2-A]QUINOXALINE DERIVATIVES AS ADENOSINE A3 RECEPTOR MODULATORS AND USES THEREOF |